These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 16507954

  • 21. [Molar pregnancy (primary or recurrent?)].
    Ayala A, Aizpuru E, Tovar JM.
    Ginecol Obstet Mex; 1989 Aug; 57():226-8. PubMed ID: 2562106
    [Abstract] [Full Text] [Related]

  • 22. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 23. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW, Cho H, Kim H, Nam EJ, Kim SW, Kim S, Kim YT, Kim JH.
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [Abstract] [Full Text] [Related]

  • 24. Serum relaxin in patients with hydatidiform mole.
    Seki K, Uesato T, Tabei T, Kato K.
    Obstet Gynecol; 1986 Mar; 67(3):381-3. PubMed ID: 3945450
    [Abstract] [Full Text] [Related]

  • 25. Re: Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following a complete hydatidiform mole: a historical database review.
    Çekmez Y, Haberal ET, Ulu İ, Gülşen S.
    BJOG; 2016 Sep; 123(10):1706. PubMed ID: 27531332
    [No Abstract] [Full Text] [Related]

  • 26. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB, Lehr M, Lewis JL.
    Surg Forum; 1973 Sep; 24():563-5. PubMed ID: 4377042
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
    Coyle C, Short D, Jackson L, Sebire NJ, Kaur B, Harvey R, Savage PM, Seckl MJ.
    Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Human Chorionic Gonadotropin Regression Curves after Partial or Complete Molar Pregnancy in Flanders: Are They Different from Regression Curves from the Eighties?
    Delattre S, Han S, Moerman P, Billen J, Goffin F, Scharpé K, Vergote I.
    Gynecol Obstet Invest; 2018 Feb; 83(1):76-82. PubMed ID: 28329740
    [Abstract] [Full Text] [Related]

  • 34. Human chorionic gonadotropin follow-up in patients with molar pregnancy: a time for reevaluation.
    Kohorn EI.
    Obstet Gynecol; 2003 Dec; 102(6):1417. PubMed ID: 14662242
    [No Abstract] [Full Text] [Related]

  • 35. [Watch out for the false low levels of hCG!].
    Flam F, Hansson LO.
    Lakartidningen; 1997 Apr 23; 94(17):1614-5. PubMed ID: 9182163
    [No Abstract] [Full Text] [Related]

  • 36. New criteria for the diagnosis of gestational trophoblastic disease.
    Romero R, Horgan JG, Kohorn EI, Kadar N, Taylor KJ, Hobbins JC.
    Obstet Gynecol; 1985 Oct 23; 66(4):553-8. PubMed ID: 2995891
    [Abstract] [Full Text] [Related]

  • 37. Endometrial sampling in patients with trophoblastic disease after suction curettage.
    Lertkhachonsuk R, Treratanachat S.
    J Reprod Med; 2008 Aug 23; 53(8):634-8. PubMed ID: 18773630
    [Abstract] [Full Text] [Related]

  • 38. Plasma prolactin, progesterone, estradiol, and human chorionic gonadotropin in complete and partial moles before and after evacuation.
    Ho PC, Wong LC, Ma HK.
    Obstet Gynecol; 1986 Jan 23; 67(1):99-106. PubMed ID: 3940346
    [Abstract] [Full Text] [Related]

  • 39. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.
    Feltmate CM, Growdon WB, Wolfberg AJ, Goldstein DP, Genest DR, Chinchilla ME, Lieberman ES, Berkowitz RS.
    J Reprod Med; 2006 Nov 23; 51(11):902-6. PubMed ID: 17165438
    [Abstract] [Full Text] [Related]

  • 40. Predictors of low risk of persistent trophoblastic disease in molar pregnancies.
    Niemann I, Petersen LK, Hansen ES, Sunde L.
    Obstet Gynecol; 2006 May 23; 107(5):1006-11. PubMed ID: 16648403
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.